Skip to main content
. 2017 Dec 22;60(12):395–402. doi: 10.3345/kjp.2017.60.12.395

Table 2. Changes in clinical parameters at each visit.

Group Variable Visit 1 Visit 2 Visit 3 Visit 4
Total (n=127) CA (yr) 8.5±0.5 9.4±0.5* 11.3±0.5* 12.0±0.6*
BA (yr) 10.1±0.7 10.9±0.6* 12.0±0.4* 12.6±0.7*
Height z score for CA 1.04±0.78 0.97±0.74* 0.50±0.77* 0.51±0.90*
Weight z score for CA 0.72±0.74 0.71±0.77 0.59±0.85* 0.52±1.06*
BMI z score for CA 0.32±0.88 0.37±0.90 0.44±0.92* 0.36±0.96
Height z score for BA −0.60±0.72 −0.45±0.60* −0.16±0.59* 0.00±0.63*
Weight z score for BA −0.39±0.85 −0.19±0.73* 0.19±0.82* 0.25±0.78*
BMI z score for BA −0.01±0.88 0.02±0.88* 0.29±0.93* 0.24±0.89*
Waist-to-height ratio 0.459±0.004 0.467±0.005* 0.469±0.005* 0.466±0.005*
Normal/overweight/obesity 97/22/8 97/22/8 97/22/8 100/16/11
Normal weight (n=97) CA (yr) 8.5±0.5 9.4±0.5* 11.2±0.5* 12.0±0.6*
BA (yr) 10.1±0.7 10.8±0.6* 11.9±0.4* 12.5±0.6*
Height z score for CA 1.00±0.80 0.93±0.76* 0.45±0.77* 0.46±0.92*
Weight z score for CA 0.45±0.60 0.45±0.63 0.29±0.66* 0.21±0.96*
BMI z score for CA −0.06±0.61 0.01±0.69 0.09±0.70* 0.00±0.76
Height z score for BA −0.62±0.72 −0.43±0.61* −0.18±0.60* 0.04±0.62*
Weight z score for BA −0.68±0.70 −0.45±0.57* −0.11±0.62* −0.04±0.57*
BMI z score for BA −0.47±0.61 −0.32±0.66* −0.07±0.70* −0.10±0.67*
Waist-to-height ratio 0.440±0.003 0.448±0.004* 0.453±0.004* 0.447±0.004
Overweight and obesity (n=30) CA (yr) 8.5±0.5 9.5±0.5* 11.4±0.5* 12.1±0.6*
BA (yr) 10.2±0.8 11.1±0.5* 12.2±0.3* 13.0±0.7*
Height z score for CA 1.15±0.72 1.07±0.69* 0.65±0.76* 0.68±0.82*
Weight z score for CA 1.61±0.40 1.56±0.54 1.57±0.62 1.54±0.65
BMI z score for CA 1.54±0.36 1.51±0.47 1.59±0.55 1.50±0.54
Height z score for BA −0.53±0.74 −0.52±0.55 −0.10±0.57* 0.05±0.65*
Weight z score for BA 0.56±0.57 0.64±0.56 1.18±0.59* 1.19±0.62*
BMI z score for BA 1.10±0.43 1.13±0.48 1.44±0.55* 1.36±0.54*
Waist-to-height ratio 0.520±0.034 0.530±0.030 0.535±0.043* 0.530±0.042

Values are presented as mean±standard deviation.

CA, chronological age; BA, bone age; BMI, body mass index; GnRH, gonadotropin-releasing hormone.

Visit 1, at the start of treatment with GnRH agonist; visit 2, at 1 year after GnRH agonist treatment; visit 3, at the end of treatment with GnRH agonist; visit 4, at 6–12 months after GnRH agonist discontinuation

*P<0.05, compared to the values at visit 1.